Finally, both apoE3 and apoE4 have a much stronger binding affinity to their receptors versus apoE2 (13), and individuals carrying the lower-affinity apoE2 isoform are protected against AD and have much less brain pathology of cerebral amyloidosis as they age (56, 57). This evidence concerns the gene APOE and Alzheimer disease.